KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Debt (2018 - 2025)

ClearPoint Neuro's Total Debt history spans 12 years, with the latest figure at $29.2 million for Q3 2025.

  • For Q3 2025, Total Debt changed N/A year-over-year to $29.2 million; the TTM value through Sep 2025 reached $29.2 million, changed N/A, while the annual FY2023 figure was $9.9 million, 0.57% up from the prior year.
  • Total Debt for Q3 2025 was $29.2 million at ClearPoint Neuro, up from $28.8 million in the prior quarter.
  • Across five years, Total Debt topped out at $29.2 million in Q3 2025 and bottomed at $9.8 million in Q4 2021.
  • The 4-year median for Total Debt is $13.7 million (2021), against an average of $16.7 million.
  • The largest YoY upside for Total Debt was 1865.74% in 2021 against a maximum downside of 60.65% in 2021.
  • A 4-year view of Total Debt shows it stood at $9.8 million in 2021, then increased by 0.56% to $9.9 million in 2022, then rose by 0.57% to $9.9 million in 2023, then skyrocketed by 193.53% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Total Debt are $29.2 million (Q3 2025), $28.8 million (Q2 2025), and $9.9 million (Q4 2023).